Scarica l'app Stockscreener
86.31
1.22%
1.04
Pre-mercato:
85.80
-0.51
-0.59%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CROX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$85.27
Aprire:
$83.42
Volume 24 ore:
1.38M
Relative Volume:
0.94
Capitalizzazione di mercato:
$4.48B
Reddito:
$4.07B
Utile/perdita netta:
$834.75M
Rapporto P/E:
6.2589
EPS:
13.79
Flusso di cassa netto:
$940.16M
1 W Prestazione:
+3.98%
1M Prestazione:
-2.91%
6M Prestazione:
-18.81%
1 anno Prestazione:
-15.91%
Intervallo 1D:
$83.42
$87.00
Intervallo di 1 settimana:
$81.00
$87.00
Portata 52W:
$73.20
$122.84
Crocs Inc Stock (CROX) Company Profile
Nome
Crocs Inc
Settore
Industria
Telefono
(303) 848-7000
Indirizzo
500 ELDORADO BOULEVARD, BROOMFIELD
Confronta CROX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CROX
Crocs Inc
|
86.31 | 4.43B | 4.07B | 834.75M | 940.16M | 13.79 |
|
NKE
Nike Inc
|
65.46 | 96.83B | 46.57B | 2.52B | 2.48B | 1.7055 |
|
ONON
On Holding Ag
|
46.62 | 15.29B | 2.64B | 275.92M | 506.27M | 0.8314 |
|
DECK
Deckers Outdoor Corp
|
101.62 | 14.86B | 5.13B | 989.67M | 880.43M | 6.5118 |
|
BIRK
Birkenstock Holding Plc
|
40.24 | 7.24B | 2.21B | 336.31M | 269.50M | 1.7962 |
Crocs Inc Stock (CROX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-09-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2025-08-08 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-08-08 | Reiterato | Monness Crespi & Hardt | Buy |
| 2025-08-08 | Downgrade | Stifel | Buy → Hold |
| 2025-07-02 | Iniziato | Goldman | Sell |
| 2025-03-12 | Aggiornamento | Loop Capital | Hold → Buy |
| 2024-11-22 | Iniziato | Needham | Buy |
| 2024-11-07 | Downgrade | Loop Capital | Buy → Hold |
| 2024-10-30 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-10-30 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2024-10-09 | Iniziato | Guggenheim | Buy |
| 2024-08-23 | Ripresa | Piper Sandler | Overweight |
| 2024-08-02 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2024-05-08 | Reiterato | Monness Crespi & Hardt | Buy |
| 2024-04-01 | Iniziato | Barclays | Overweight |
| 2024-02-07 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2023-12-12 | Iniziato | BofA Securities | Buy |
| 2023-11-28 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-10-20 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2023-09-07 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-07-28 | Aggiornamento | Stifel | Hold → Buy |
| 2023-06-14 | Iniziato | Raymond James | Mkt Perform |
| 2023-03-30 | Iniziato | B. Riley Securities | Buy |
| 2022-09-21 | Iniziato | Exane BNP Paribas | Neutral |
| 2022-07-26 | Ripresa | Piper Sandler | Overweight |
| 2022-07-05 | Aggiornamento | Loop Capital | Hold → Buy |
| 2022-04-29 | Iniziato | Wedbush | Outperform |
| 2022-04-04 | Downgrade | Loop Capital | Buy → Hold |
| 2022-01-18 | Iniziato | Seaport Research Partners | Neutral |
| 2021-09-15 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-07-23 | Reiterato | B. Riley Securities | Buy |
| 2021-07-23 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-04-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-02-19 | Reiterato | Pivotal Research Group | Buy |
| 2021-01-13 | Reiterato | Monness Crespi & Hardt | Buy |
| 2021-01-12 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-28 | Reiterato | B. Riley Securities | Buy |
| 2020-10-28 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-10-20 | Reiterato | Pivotal Research Group | Buy |
| 2020-10-14 | Reiterato | B. Riley Securities | Buy |
| 2020-10-14 | Reiterato | Piper Sandler | Overweight |
| 2020-08-25 | Aggiornamento | B. Riley FBR | Neutral → Buy |
| 2020-07-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-07-22 | Iniziato | UBS | Neutral |
| 2020-07-17 | Downgrade | CL King | Buy → Neutral |
| 2020-06-30 | Aggiornamento | Loop Capital | Hold → Buy |
| 2020-06-08 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-05-22 | Iniziato | B. Riley FBR | Neutral |
| 2020-04-21 | Reiterato | Pivotal Research Group | Buy |
| 2020-03-31 | Iniziato | Loop Capital | Hold |
| 2020-03-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-02-24 | Reiterato | Pivotal Research Group | Buy |
| 2020-01-15 | Reiterato | Monness Crespi & Hardt | Buy |
| 2020-01-15 | Reiterato | Pivotal Research Group | Buy |
| 2019-10-31 | Reiterato | Monness Crespi & Hardt | Buy |
| 2019-09-17 | Reiterato | Piper Jaffray | Overweight |
Mostra tutto
Crocs Inc Borsa (CROX) Ultime notizie
Crocs Bets $150 Clogs Shaped Like Lego Bricks Will Generate Buzz - Bloomberg.com
What's Going On With Crocs Stock Today? - Benzinga
Crocs Analyst Turns Bearish, Revises 2026 Estimates Lower - Benzinga
Crocs, Inc. Announces Conference Call to Review Fourth Quarter a - GuruFocus
Crocs, Inc. Announces Conference Call to Review Fourth Quarter and Full Year 2025 Earnings Results - Yahoo Finance
Migdal Insurance & Financial Holdings Ltd. Invests $16.71 Million in Crocs, Inc. $CROX - MarketBeat
Patient Capital Management LLC Has $49.19 Million Stake in Crocs, Inc. $CROX - MarketBeat
Crocs Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Crocs, Inc.CROX - PR Newswire
Weekly Earnings: Is AIFF gaining market shareJuly 2025 Momentum & Real-Time Volume Spike Alerts - baoquankhu1.vn
CROCS INC (NASDAQ:CROX) Presents a Compelling Value Investment Case - Chartmill
Does Crocs Inc. have strong EBITDA marginsMarket Trend Summary & Weekly Breakout Watchlists - bollywoodhelpline.com
Why analysts upgrade Crocs Inc. stockCPI Data & Safe Swing Trade Setup Alerts - bollywoodhelpline.com
EULAV Asset Management Sells 32,600 Shares of Crocs, Inc. $CROX - MarketBeat
CROX Stock Price, Forecast & Analysis | CROCS INC (NASDAQ:CROX) - Chartmill
Deadlines and Discretion: Appeal Trips Over the Clock - The National Law Review
Crocs, Inc.'s (NASDAQ:CROX) Price Is Out Of Tune With Revenues - 富途资讯
Crocs, Inc. (NASDAQ:CROX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Can Crocs navigate tariff risks and protect margins in 2026? - MSN
Crocs and Israel: Political neutrality or support? - Brussels Morning
Crocs’ Bid to Block Copycat Clogs Ends in Mixed Result on Appeal - The Fashion Law
State of Alaska Department of Revenue Acquires 19,526 Shares of Crocs, Inc. $CROX - MarketBeat
Crocs (CROX) Rises Higher Than Market: Key Facts - sharewise.com
Macaulay Culkin on 'becoming a Crocs guy' as actor makes a surprise TikTok Shop appearance for the shoe brand - MSN
Here's Why You Should Retain Crocs Stock in Your Portfolio - The Globe and Mail
Will Crocs Inc. stock deliver strong dividend growth2025 Price Action Summary & Free High Return Stock Watch Alerts - ulpravda.ru
A Look At Crocs (CROX) Valuation After Recent Share Price Momentum - Yahoo Finance
How Crocs Inc. stock performs in interest rate cyclesJobs Report & High Accuracy Swing Trade Signals - ulpravda.ru
Can Crocs Inc. stock sustain market leadershipJuly 2025 Short Interest & Low Drawdown Momentum Ideas - Улправда
Fed. Circ. Says Crocs' Appeal Of Split ITC Loss Came Too Late - Law360
BWG Global Upgrades Crocs (CROX) - Nasdaq
How Crocs Inc. stock trades during market volatilityJuly 2025 Setups & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Is Crocs Inc. stock overvalued by current metricsWeekly Gains Report & Verified Momentum Stock Ideas - ulpravda.ru
Crocs Fails to Revive Bid for Import Ban at Federal Circuit (1) - Bloomberg Law News
Analyst Upgrade: Is Crocs Inc. stock safe for conservative investorsDividend Hike & Free Safe Capital Growth Stock Tips - ulpravda.ru
CX Institutional Takes Position in Crocs, Inc. $CROX - MarketBeat
Crocs (CROX) Dips More Than Broader Market: What You Should Know - sharewise.com
Why Crocs (CROX) Shares Are Sliding Today - Finviz
Baird Downgrades Crocs to Neutral From Outperform, Price Target is $100 - MarketScreener
Where Crocs Stands With Analysts - Benzinga
Is Crocs (CROX) Now Attractively Priced After A 19.8% One Year Share Price Decline - Yahoo Finance
Crocs: Best-In-Class Operating Margins And ROE (CROX) - Seeking Alpha
UBS reiterates Neutral rating on Crocs stock, maintains $85 price target - Investing.com UK
Allspring Global Investments Holdings LLC Sells 109,756 Shares of Crocs, Inc. $CROX - MarketBeat
Retail Trends: Is Crocs Inc stock safe for conservative investorsEarnings Growth Report & AI Optimized Trading Strategy Guides - moha.gov.vn
Cwm LLC Grows Stock Holdings in Crocs, Inc. $CROX - InsuranceNewsNet
Crocs: Priced For Failure, Positioned For Upside - Seeking Alpha
Can Crocs Navigate Tariff Risks and Protect Margins in 2026? - The Globe and Mail
Crocs (CROX) registers a bigger fall than the market: Important facts to note - MSN
Crocs (CROX) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Weekly Earnings: Is Green Thumb Industries Inc R9U2 stock considered safe haven2025 Growth vs Value & Detailed Earnings Play Strategies - moha.gov.vn
Fort Washington Investment Advisors Inc. OH Grows Stock Position in Crocs, Inc. $CROX - MarketBeat
Crocs Inc Azioni (CROX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Crocs Inc Azioni (CROX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Healy Susan L. | EVP, Chief Financial Officer |
Aug 12 '25 |
Buy |
76.56 |
2,000 |
153,120 |
50,078 |
| REPLOGLE JOHN B | Director |
Aug 08 '25 |
Buy |
76.69 |
3,261 |
250,084 |
15,417 |
| SMACH THOMAS J | Director |
May 09 '25 |
Sale |
109.47 |
9,139 |
1,000,446 |
109,458 |
| Bickley Ian | Director |
May 12 '25 |
Sale |
115.89 |
3,044 |
352,784 |
27,505 |
0.09%
9.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):